Home Tools
Log in
Cart

Vidofludimus

Catalog No. T2601   CAS 717824-30-1
Synonyms: SC12267, 4sc-101

Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Vidofludimus Chemical Structure
Vidofludimus, CAS 717824-30-1
Pack Size Availability Price/USD Quantity
2 mg In stock $ 54.00
5 mg In stock $ 77.00
10 mg In stock $ 126.00
25 mg In stock $ 230.00
50 mg In stock $ 369.00
100 mg In stock $ 522.00
1 mL * 10 mM (in DMSO) In stock $ 61.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.58%
Purity: 99.46%
Purity: 99.22%
Purity: 99.15%
Purity: 98.83%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
Targets&IC50 DHODH (human):134 nM
In vitro Vidofludimus causes a concentration dependent inhibition of phytohemagglutinin-stimulated PBMC proliferation via the inhibition of pyrimidine de novo synthesis. [1] Vidofludimus attenuates IL-17 secretion from colonic strips by inhibition of STAT3 and NF-κB activation. [2]
In vivo In MRLlpr/lpr mice, Vidofludimus (300 mg/kg, p.o.) reduces systemic autoimmunity and improves Lupus Nephritis. [1] In Rats, Vidofludimus (60 mg/kg, p.o.) effectively reduces macroscopic and histological pathology and the numbers of CD3+ T cells. [2] In a rat model of renal transplantation, Vidofludimus (20 mg/kg, p.o.) prolongs survival, paralleled by amelioration of histologic signs of acute rejection. [3]
Kinase Assay DHODH inhibition assay: In vitro DHODH inhibition assay mixture contains 50 μM decycloubiquinone, 100 μM dihydroorotate, and 60 μM 2,6-dichloroindophenol. The amount of enzyme is adjusted such that an average slope of approximately 0.2 AU/min will be achieved in the assay for the positive control (eg, without inhibitor). Measurements are conducted in 50 mM TrisHCl, 150 mM KCl, 0.1% Triton X-100, and pH 8.0 at 30°C in a final volume of 1 ml. The components are mixed, and the reaction is started by adding dihydroorotate. The reaction is followed spectrophotometrically by measuring the decrease in absorption at 600 nm for 2 minutes. The assay is linear in time and enzyme concentration. Inhibitory studies are conducted in a standard assay with additional variable amounts of inhibitor. For the determination of the IC50 values (concentration of inhibitor required for 50% inhibition), eight different inhibitor concentrations are applied. Each data point is recorded in triplicates on a single measurement day.
Synonyms SC12267, 4sc-101
Molecular Weight 355.36
Formula C20H18FNO4
CAS No. 717824-30-1

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

H2O: < 1 mg/mL (insoluble or slightly soluble)

DMSO: 100 mg/mL (281.4 mM)

Ethanol: 1 mg/mL (2.81 mM)

TargetMolReferences and Literature

1. Kulkarni OP, et al. Am J Pathol. 2010, 176(6), 2840-2847. 2. Fitzpatrick LR, et al. J Pharmacol Exp Ther. 2012, 342(3), 850-860. 3. Rusai K, et al. Transplantation. 2012, 93(11), 1101-1107. 4. Qiu X, Jiang S, Xiao Y, et al. SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation[J]. International Journal of Oral Science. 2021, 13(1): 1-9. 5. Zhu Y, Xu S, Lu Y, et al. Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD[J]. Frontiers in Pharmacology. 2020, 11.

TargetMolCitations

1. Zhu Y, Xu S, Lu Y, et al. Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD. Frontiers in Pharmacology. 2020, 11 2. Qiu X, Jiang S, Xiao Y, et al. SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation. International Journal of Oral Science. 2021, 13(1): 1-9.

Related compound libraries

This product is contained In the following compound libraries:
Drug Repurposing Compound Library Anti-Cancer Drug Library Inhibitor Library Anti-Cancer Clinical Compound Library Anti-Neurodegenerative Disease Compound Library Anti-Cancer Metabolism Compound Library DNA Damage & Repair Compound Library Metabolism Compound Library Immunology/Inflammation Compound Library Bioactive Compounds Library Max

Related Products

Related compounds with same targets
ALDH1A3-IN-2 Mutant IDH1-IN-1 DHODH-IN-13 Galloflavin ALDH1A3-IN-3 Methotrexate disodium Tenuifoliside B DSM421

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Vidofludimus 717824-30-1 Cell Cycle/Checkpoint DNA Damage/DNA Repair Immunology/Inflammation Metabolism DNA/RNA Synthesis Dehydrogenase Interleukin DHODH SC-12267 fatty liver Inhibitor SC12267 Dihydroorotate Dehydrogenase dihydroorotate dehydrogenase (DHODH) oral 4sc-101 Interleukin Related FXR NR1H4 non-alcoholic fatty liver disease (NAFLD) inflammatory bowel disease (IBD) immunomodulatory farnesoid X receptor (FXR) inhibit SC 12267 inhibitor

 

TargetMol